F8 ENT (08347) announced its financial results for the six months ended September 30, 2025. The company reported revenue of HK$135 million, a decrease of 26.8% year-on-year. However, net profit rose to HK$3.45 million, marking an 82% increase compared to the same period last year. Basic earnings per share stood at HK2.51 cents. The growth in net profit was primarily attributed to reduced cost of sales and lower operational expenses.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments